Evidence map›Paper›PMID 23397215›Full record

ReviewCurrent hypertension reports2013

A consideration of genetic mechanisms behind the development of hypertension in blacks.

Wanzhu Tu, J Howard Pratt

Open access · greenAbstract readReview
In one paragraph

Review in Current hypertension reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Living with Hypertension: A Qualitative Research.International journal of community based nursing and midwifery · 2017
    Article
  10. Article
  11. Loop Diuretics in the Treatment of Hypertension.Current hypertension reports · 2016
    Review
  12. Review
  13. HCV, but not HIV, is a risk factor for cerebral small vessel disease.Neurology(R) neuroimmunology & neuroinflammation · 2014
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Wanzhu TuDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
J Howard Pratt
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI RODRIGUEZ, HENRY · 1985 to 2008
$25.5M
Genetic Determinants of Sodium RetentionR01HL035795 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI PRATT, JOHN HOWARD · 1985 to 2006
$2.9M
Effects of Somatic Growth and Sodium Retention on Blood PressureR01HL095086 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI PRATT, JOHN HOWARD, TU, WANZHU · 2009 to 2012
$1.5M
NCRR NIH HHS M01 RR000750NHLBI NIH HHS R01 HL035795NHLBI NIH HHS R01 HL095086
6 · The paper itself

Abstract

Hypertension is a more serious disease in blacks. The determinants of the blood pressure (BP) may be uniquely different from those in whites. The characteristic low-renin, salt-sensitive hypertension of blacks is consistent with the kidney reabsorbing additional sodium (Na), which leads to an expanded plasma volume that drives the BP. Mechanisms considered are genetically based. These include: (1) the intra-renal renin-angiotensin system (RAS), one based on molecular variations in angiotensinogen; (2) the Na, K, 2Cl cotransporter (NKCC2) and its regulators in the thick ascending limb, which are associated with a variety of phenotypes consistent with a more active cotransporter in blacks; and (3) the genes for MYH9 and APOL 1, which have been associated with kidney disease in blacks. To achieve a state of hypertension, an increase in Na uptake in proximal nephron regions may require a distal nephron that does not fully adjust due to less than adequate suppression of aldosterone production.

Indexed as

Apolipoprotein L1ApolipoproteinsBlack PeopleBlood PressureHumansHypertensionKidneyLipoproteins, HDLMolecular Motor ProteinsMyosin Heavy ChainsRenin-Angiotensin SystemSodium-Potassium-Chloride SymportersSolute Carrier Family 12, Member 1APOL1 protein, humanApolipoprotein L1ApolipoproteinsLipoproteins, HDLMolecular Motor ProteinsMYH9 protein, humanMyosin Heavy ChainsSLC12A1 protein, humanSodium-Potassium-Chloride SymportersSolute Carrier Family 12, Member 1

Identifiers

PMID23397215
PMCPMC3594543
OpenAlexW2073120236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.